266 related articles for article (PubMed ID: 27697500)
1. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.
de la Morena MT; Leonard D; Torgerson TR; Cabral-Marques O; Slatter M; Aghamohammadi A; Chandra S; Murguia-Favela L; Bonilla FA; Kanariou M; Damrongwatanasuk R; Kuo CY; Dvorak CC; Meyts I; Chen K; Kobrynski L; Kapoor N; Richter D; DiGiovanni D; Dhalla F; Farmaki E; Speckmann C; Español T; Shcherbina A; Hanson IC; Litzman J; Routes JM; Wong M; Fuleihan R; Seneviratne SL; Small TN; Janda A; Bezrodnik L; Seger R; Raccio AG; Edgar JD; Chou J; Abbott JK; van Montfrans J; González-Granado LI; Bunin N; Kutukculer N; Gray P; Seminario G; Pasic S; Aquino V; Wysocki C; Abolhassani H; Dorsey M; Cunningham-Rundles C; Knutsen AP; Sleasman J; Costa Carvalho BT; Condino-Neto A; Grunebaum E; Chapel H; Ochs HD; Filipovich A; Cowan M; Gennery A; Cant A; Notarangelo LD; Roifman CM
J Allergy Clin Immunol; 2017 Apr; 139(4):1282-1292. PubMed ID: 27697500
[TBL] [Abstract][Full Text] [Related]
2. Hyper IgM Syndrome: a Report from the USIDNET Registry.
Leven EA; Maffucci P; Ochs HD; Scholl PR; Buckley RH; Fuleihan RL; Geha RS; Cunningham CK; Bonilla FA; Conley ME; Ferdman RM; Hernandez-Trujillo V; Puck JM; Sullivan K; Secord EA; Ramesh M; Cunningham-Rundles C
J Clin Immunol; 2016 Jul; 36(5):490-501. PubMed ID: 27189378
[TBL] [Abstract][Full Text] [Related]
3. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.
Slack J; Albert MH; Balashov D; Belohradsky BH; Bertaina A; Bleesing J; Booth C; Buechner J; Buckley RH; Ouachée-Chardin M; Deripapa E; Drabko K; Eapen M; Feuchtinger T; Finocchi A; Gaspar HB; Ghosh S; Gillio A; Gonzalez-Granado LI; Grunebaum E; Güngör T; Heilmann C; Helminen M; Higuchi K; Imai K; Kalwak K; Kanazawa N; Karasu G; Kucuk ZY; Laberko A; Lange A; Mahlaoui N; Meisel R; Moshous D; Muramatsu H; Parikh S; Pasic S; Schmid I; Schuetz C; Schulz A; Schultz KR; Shaw PJ; Slatter MA; Sykora KW; Tamura S; Taskinen M; Wawer A; Wolska-Kuśnierz B; Cowan MJ; Fischer A; Gennery AR; ; ; ;
J Allergy Clin Immunol; 2018 Jan; 141(1):322-328.e10. PubMed ID: 28392333
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome.
Dimitrova D; Nademi Z; Maccari ME; Ehl S; Uzel G; Tomoda T; Okano T; Imai K; Carpenter B; Ip W; Rao K; Worth AJJ; Laberko A; Mukhina A; Néven B; Moshous D; Speckmann C; Warnatz K; Wehr C; Abolhassani H; Aghamohammadi A; Bleesing JJ; Dara J; Dvorak CC; Ghosh S; Kang HJ; Markelj G; Modi A; Bayer DK; Notarangelo LD; Schulz A; Garcia-Prat M; Soler-Palacín P; Karakükcü M; Yilmaz E; Gambineri E; Menconi M; Masmas TN; Holm M; Bonfim C; Prando C; Hughes S; Jolles S; Morris EC; Kapoor N; Koltan S; Paneesha S; Steward C; Wynn R; Duffner U; Gennery AR; Lankester AC; Slatter M; Kanakry JA
J Allergy Clin Immunol; 2022 Jan; 149(1):410-421.e7. PubMed ID: 34033842
[TBL] [Abstract][Full Text] [Related]
6. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.
Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J;
J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.
Wingard JR; Majhail NS; Brazauskas R; Wang Z; Sobocinski KA; Jacobsohn D; Sorror ML; Horowitz MM; Bolwell B; Rizzo JD; Socié G
J Clin Oncol; 2011 Jun; 29(16):2230-9. PubMed ID: 21464398
[TBL] [Abstract][Full Text] [Related]
8. Conditional Survival, Cause-Specific Mortality, and Risk Factors of Late Mortality After Allogeneic Hematopoietic Cell Transplantation.
Wong FL; Teh JB; Atencio L; Stiller T; Kim H; Chanson D; Forman SJ; Nakamura R; Armenian SH
J Natl Cancer Inst; 2020 Nov; 112(11):1153-1161. PubMed ID: 32044955
[TBL] [Abstract][Full Text] [Related]
9. Changes in Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study.
Hingorani S; Pao E; Stevenson P; Schoch G; Laskin BL; Gooley T; McDonald GB
Clin J Am Soc Nephrol; 2018 Jun; 13(6):866-873. PubMed ID: 29669818
[TBL] [Abstract][Full Text] [Related]
10. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.
Bhatia S; Francisco L; Carter A; Sun CL; Baker KS; Gurney JG; McGlave PB; Nademanee A; O'Donnell M; Ramsay NK; Robison LL; Snyder D; Stein A; Forman SJ; Weisdorf DJ
Blood; 2007 Nov; 110(10):3784-92. PubMed ID: 17671231
[TBL] [Abstract][Full Text] [Related]
11. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
Allewelt H; Martin PL; Szabolcs P; Chao N; Buckley R; Parikh S
Pediatr Blood Cancer; 2015 Dec; 62(12):2216-22. PubMed ID: 26291959
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan.
Mitsui-Sekinaka K; Imai K; Sato H; Tomizawa D; Kajiwara M; Nagasawa M; Morio T; Nonoyama S
J Allergy Clin Immunol; 2015 Oct; 136(4):1018-24. PubMed ID: 25840720
[TBL] [Abstract][Full Text] [Related]
14. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia.
Llaurador G; Shaver K; Wu M; Wang T; Gillispie A; Doherty E; Craddock J; Read J; Yassine K; Morales E; George A; Steffin D; Krance R; Martinez C; Heslop H; Salem B
Transplant Cell Ther; 2024 Feb; 30(2):217-227. PubMed ID: 37931800
[TBL] [Abstract][Full Text] [Related]
15. Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation.
Armenian SH; Xiao M; Berano Teh J; Lee B; Chang HA; Mascarenhas K; Lee S; Iukuridze A; Xie JJ; Scott JM; Jones LW; Lennie Wong F; Forman SJ; Nakamura R
J Natl Cancer Inst; 2019 Aug; 111(8):837-844. PubMed ID: 30951603
[TBL] [Abstract][Full Text] [Related]
16. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
17. Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience.
Al-Saud B; Al-Jomaie M; Al-Ghonaium A; Al-Ahmari A; Al-Mousa H; Al-Muhsen S; Al-Seraihy A; Arnaout R; Elshorbagi S; Al-Dhekri H; Ayas M
Bone Marrow Transplant; 2019 Jan; 54(1):63-67. PubMed ID: 29884852
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
Wang CY; Ren HY; Qiu ZX; Wang Y; Cen XN; Wang LH; Wang MJ; Xu WL; Wang WS; Li Y; Dong YJ; Ou JP; Liang ZY; Liu W; Wang Q
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):659-63. PubMed ID: 23978015
[TBL] [Abstract][Full Text] [Related]
19. Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell transplantation.
Rajpal JS; Patel N; Vogel RI; Kashtan CE; Smith AR
Biol Blood Marrow Transplant; 2013 Apr; 19(4):661-5. PubMed ID: 23266833
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
Friedman DN; Hilden P; Moskowitz CS; Suzuki M; Boulad F; Kernan NA; Wolden SL; Oeffinger KC; Sklar CA
Biol Blood Marrow Transplant; 2017 Mar; 23(3):475-482. PubMed ID: 28040534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
